We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01395550
First Posted: July 15, 2011
Last Update Posted: August 30, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
AstraZeneca
  Purpose
AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.

Condition
Cardiovascular Events

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.

Further study details as provided by AstraZeneca:

Enrollment: 88
Study Start Date: January 2010
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with cardiovascular events
Criteria

Inclusion Criteria:

  • All patients who has experienced cardiovascular events

Exclusion Criteria:

  • Patients with no cardiovascular events.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: AstraZeneca
ClinicalTrials.gov Identifier: NCT01395550     History of Changes
Other Study ID Numbers: NIS-CZA-XXX-2011/1
First Submitted: June 14, 2011
First Posted: July 15, 2011
Last Update Posted: August 30, 2011
Last Verified: August 2011